Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Piloni, T. Oggionni, L. Diachyshyna, L. Scelsi, S. Ghio, C. Raineri, I. Cerveri, A. Cascina, F. Meloni (Pavia, Italy). Out of proportion PH in COPD: Report of a small case series. Eur Respir J 2013; 42: Suppl. 57, 2647

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD: points to ponder Year: 2014 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Management of virtual COPD cases by pulmonary physicians Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Eosinophilic airway inflammation as a complication of COPD, and the usefulness of ICS on these cases Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Misdiagnosed COPD: systematic review and meta-analysis Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007 Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators Source: International Congress 2014 – Clinical presentations Year: 2014 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Clinical case on COPD: an unexpectedly long story with an unforeseen end Source: Annual Congress 2007 - Clinical Grand Round: an interactive session Year: 2007 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016